Retatrutide, with reservations

Retatrutide is the newest of the three, and its record is honest about being young — grade B, trial-phase, ranges that admit more daylight than an approved label would. The schedule that emerges from the early work runs 2000 micrograms weekly, stepping by the same amount each fourth week to 12000.

Practically: a ten milligram vial, two millilitres of diluent, forty units for the first draw — arithmetic the page will repeat for any combination you enter. What it will not do is launder the uncertainty; the grade-B note travels with every result, and we would rather a tool admit that than pretend otherwise.